Skip to content
Balance Sheet · TASI 8210

Bupa Arabia for Cooperative Insurance Co.
Cash and cash equivalents history.

Cash and near-cash balances reported at the reporting date. Explore 15 reported observations from 2023 to 2026, with every value linked to its official evidence.

Coverage2023–202615 source-linked periods
Annual history3annual reporting periods
Interim history12quarterly or year-to-date periods
StatementBalance Sheetas reported by the issuer
Annual series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2025IFRS 17Cash and cash equivalents1.43B SAR
Cash and cash equivalents0500M1B1.5B202320242025
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents832.83M SAR
Cash and cash equivalents0500M1B1.5B2B2.5B2023202420252026
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents1.25B SAR
Cash and cash equivalents0500M1B1.5B2B2023202420252026
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents1.33B SAR
Cash and cash equivalents0500M1B1.5B2023202420252026
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20262026-09-301,328,64330 September 20261.33B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20262026-06-301,252,85130 June 20261.25B SARCash and cash equivalentsOfficial p. 4 ↗Open statement →
Q1 20262026-03-31832,82731 March 2026 (Unaudited)832.83M SARCash and cash equivalentsNote 4Signed copy p. 4 ↗Saudi Exchange filing ↗Open statement →
FY 20252025-12-311,433,5182025-12-311.43B SARCash and cash equivalentsNote 5Official p. 8 ↗Open statement →
9M / Q3 20252025-09-30709,72430 September 2025 · SAR’000709.72M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20252025-06-301,641,56930 June 2025 · SAR’0001.64B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
Q1 20252025-03-31598,05331 March 2025 · SAR’000598.05M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
FY 20242024-12-31925,1902024-12-31925.19M SARCash and cash equivalentsNote 5Official p. 8 ↗Open statement →
9M / Q3 20242024-09-30936,22930 September 2024 · SAR’000936.23M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20242024-06-301,733,69330 June 2024 · SAR’0001.73B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
Q1 20242024-03-311,237,52431 March 2024 · SAR’0001.24B SARCash and cash equivalentsOfficial p. 4 ↗Open statement →
FY 20232023-12-31Comparative figures in an audited report1,255,8962023-12-311.26B SARCash and cash equivalentsNote 5Official p. 8 ↗Open statement →
9M / Q3 20232023-09-301,415,73330 September 2023 · SAR’0001.42B SARCash and cash equivalentsOfficial p. 4 ↗Open statement →
H1 / Q2 20232023-06-301,536,07130 June 2023 · SAR’0001.54B SARCash and cash equivalentsNote 5Official p. 4 ↗Open statement →
Q1 20232023-03-312,154,49331 March 2023 · SAR’0002.15B SARCash and cash equivalentsNote 5Official p. 4 ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

بوبا العربية — Cash and cash equivalents

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.